This brand name is authorized in Austria, Canada, Spain, Finland, Hong Kong, New Zealand, Poland, Singapore, United Kingdom, United States, South Africa
The drug VIVOTIF contains one active pharmaceutical ingredient (API):
|
1
Typhoid, live attenuated
UNII 0MZI008M96 - SALMONELLA TYPHI TY21A LIVE ANTIGEN
|
|
Typhoid, live attenuated, vaccine contains strains of Salmonella typhi, the etiological agent of typhoid fever, an acute, febrile enteric disease. The S. typhi Ty21a vaccine strain, by virtue of a reduction in enzymes essential for lipopolysaccharide biosynthesis, is restricted in its ability to produce complete lipopolysaccharide. However, a sufficient quantity of complete lipopolysaccharide is synthesized to evoke a protective immune response. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VIVOTIF Typhoid vaccine capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AP01 | Typhoid, oral, live attenuated | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AP Typhoid vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 00885975 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 83589 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 387416 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 29992 |
| Country: HK | Department of Health Drug Office | Identifier(s): 55557 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 12233 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100386090 |
| Country: SG | Health Sciences Authority | Identifier(s): 02260P |
| Country: US | FDA, National Drug Code | Identifier(s): 50090-2292, 69401-000 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): T/30.1/628 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
